Marshall Wace

Activity in this selectionhbm-healthcare-bb732a39

By stage

Series A1

Series B1

Series C+1

Biotech3

United States2

United Kingdom1

3 in this selection

Jul 14

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries B

Role not disclosed

Feb 4

Develops novel multifunctional antibodies for oncology and immunology & inflammation indications

$52MSeries A+

Role not disclosed

Jan 8

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F

Role not disclosed